Nordic ListingsIssuer Report
XP Chemistries AB: Quarterly Trading Report 2025 Q3
XP Chemistries AB: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=b498ea156d82f48e5c6d580c116121ba8&lang=en&src=omxlink
XP Chemistries AB: Quarterly Trading Report 2025 Q3
Earlier from Xp Chemistries Ab
- XPC: EU approval paves way for commercial launch; rights issue boosts capital for growth
- XPC: EFSA approval for capsaicin positions XP Chemistries for EU market launch in 2025
- XPC: Narrowed losses and regulatory progress position XP Chemistries for a 2025 commercial launch
- XPC: Q3 2024 saw lower sales, improved losses, and a regulatory delay for XP Chemistries